about
An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versaRole of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancerEpigenetic roles in the malignant transformation of gastric mucosal cellsThe role of piRNA and its potential clinical implications in cancerEpigenome-based personalized medicine in human cancerGastric Cancer in the Era of Precision Medicine.VEZT, a novel putative tumor suppressor, suppresses the growth and tumorigenicity of gastric cancer.DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.DACT2 is frequently methylated in human gastric cancer and methylation of DACT2 activated Wnt signaling.MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM.Proteomics-Based Identification and Analysis of Proteins Associated with Helicobacter pylori in Gastric Cancer.Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach.What gastric cancer proteomic studies show about gastric carcinogenesis?BET inhibition as a new strategy for the treatment of gastric cancer.Epigenetically downregulated Semaphorin 3E contributes to gastric cancerThe prognostic value of UHRF-1 and p53 in gastric cancer.DNA and histone methylation in gastric carcinogenesisInvolvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2)Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer.Epigenetic modifications induced by Helicobacter pylori infection through a direct microbe-gastric epithelial cells cross-talk.Helicobacter pylori-Induced Chronic Gastritis and Assessing Risks for Gastric Cancer.MicroRNAs in gastric cancer: from benchtop to bedside.MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.Microsatellite instability: an update.Methyl-CpG-Binding Protein (MBD) Family: Epigenomic Read-Outs Functions and Roles in Tumorigenesis and Psychiatric Diseases.MicroRNA-103a inhibits gastric cancer cell proliferation, migration and invasion by targeting c-Myb.Epidermal growth factor receptor-coamplified and overexpressed protein (VOPP1) is a putative oncogene in gastric cancer.RKIP suppresses gastric cancer cell proliferation and invasion and enhances apoptosis regulated by microRNA-224.Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation.The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer.MicroRNA-212 inhibits proliferation of gastric cancer by directly repressing retinoblastoma binding protein 2.Silencing the YB-1 gene inhibits cell migration in gastric cancer in vitro.Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells.MicroRNA-561 inhibits gastric cancercell proliferation and invasion by downregulating c-Myc expression.MiR-330-3p inhibits gastric cancer progression through targeting MSI1.Upregulation of T-cadherin suppresses cell proliferation, migration and invasion of gastric cancer in vitro.Reduced mRNA expression levels of MBD2 and MBD3 in gastric carcinogenesis.Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis.Identification and validation of a prognostic 9-genes expression signature for gastric cancer.MiR-143 inhibits cell proliferation and invasion by targeting DNMT3A in gastric cancer.
P2860
Q27027592-5994DD0F-189D-4266-B98E-40AE912EB6EBQ28067449-2A11A416-7B18-4357-A5BE-7FE422FE1480Q28070086-303740DB-D839-48E1-B208-52932413D760Q28083603-E2A1DBD5-FF09-4580-8D41-3F944142CC83Q28083951-D013FF53-6219-4053-B1F2-6B15CBD6CB72Q33600457-7F3707B8-8A34-410E-80A0-470E97AC25E9Q34373527-1ECFCD85-CEA9-43BB-A798-A98AC9385C12Q34603514-E2B0042C-4146-4EB2-9BA8-EF1DC6BAC2F8Q34704853-42C3B0B0-665A-4962-8373-1C7EDFE7184CQ34764403-F23E9690-269D-4FA7-9FF9-85D5E4EC7A95Q35888753-3A0A0565-8D6E-4F43-A952-E75DAC587A37Q35904485-0F258C56-57E3-479C-B174-0151E85C3609Q36002404-8D702953-2D99-45EC-A13E-0A5F533702C5Q36040347-CF1950D3-0686-4B7E-BDB5-0718F44FCBE3Q36299715-164485B8-8F49-452A-B180-DDD206A0C8A3Q36606770-94FF4C65-0FBB-4A09-A151-BC00C94573B0Q36654458-70688A3B-95DC-4BC2-9BBE-39217988F12FQ37139148-21030A37-8B7B-4B74-92A6-5217D9786A79Q37299306-7CD3C521-8D45-4D0E-B2CA-ED0063B39CE9Q38110164-94069B98-54CA-42C5-9853-3816FE517F75Q38132130-1B39C5D1-1E50-4B99-A985-0B90F7EF73F9Q38151490-F4FCF0AA-D2E0-415B-BF56-A82DD4CB43CDQ38202662-5BD88951-00EA-4049-A19F-B505090AC567Q38363519-EEEFB87C-BD36-41DF-AC68-980C814F9BDEQ38553124-FC17D11C-3336-4CC0-8FEF-4F42FA335A63Q38926425-DD3B4D3B-0121-4E36-930C-7B1D2D64A741Q38940301-D94554B4-0E49-452E-9B3F-5977486C2398Q38975876-C81821E1-6794-42D4-8B89-1F7BC452D706Q39096573-8C3762F0-C9E8-4F90-A830-5D15B02BB0C5Q39099794-6C1B23FD-7697-4587-A5EF-E06A45C52267Q39136095-20348876-AE7E-4555-9A5D-5DEF6CFAEA20Q39161502-9AAE7497-FA87-4E86-A61A-1F350480BD24Q39221459-BCBF69DB-D3EB-4C10-8422-C14B9E317BD6Q41210209-8FDB0008-95E0-40EB-A118-6A1D43F21A99Q42178342-F6E5804E-6A00-4FE6-BE53-54E0C24765BAQ43021890-3615386D-43B3-49C5-8E72-CD2F06646B1FQ44401460-E3F6DCD4-3E32-4836-881A-8828FEFA7A34Q44952417-2F4C6554-BDCB-4758-90EE-DA55A81E2363Q47240879-5E0B5B9F-E2F8-44B6-891F-7AF1C64EEE4BQ50884607-F30C7EF5-5872-492E-BE25-FFC2EFE5B8EA
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epigenetic mechanisms in gastric cancer.
@en
type
label
Epigenetic mechanisms in gastric cancer.
@en
prefLabel
Epigenetic mechanisms in gastric cancer.
@en
P2093
P2860
P356
P1433
P1476
Epigenetic mechanisms in gastric cancer.
@en
P2093
Carolina Oliveira Gigek
Danielle Queiroz Calcagno
Fernanda Wisnieski
Marilia Arruda Cardoso Smith
Rommel Rodriguez Burbano
P2860
P304
P356
10.2217/EPI.12.22
P577
2012-06-01T00:00:00Z